Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial

Moszak, Małgorzata; Zawada, Agnieszka; Juchacz, Aldona; Grzymisławski, Marian; Bogdański, Paweł

doi:10.1186/s12944-020-01330-7

Lipids in Health and Disease

Table 4 Comparison of anthropometric parameters in the RO, AO and C groups at the beginning of the study and the end of study (EOS)

From: Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial

Variable	RO group (n = 26)				AO group (n = 26)				C group (n = 29)				P
Variable	Before	After	Δ	P	Before	After	Δ	P	Before	After	Δ	P
Weight, kg	120.5 (102.9–135)	114.9 (97.7–128.2)	−5.6	0.000^d	118.5 (108.0–132.4)	111.9 (106.5–126.0)	−6.6	0.000^d	115.0 (101.4–133.3)	108.0 (96.4–127.0)	−7.0	0.001^d	0.100^b
BMI, kg/m²	39.8 (36.9–44.0)	39.1 (34.9–41.9)	−0.7	0.001^d	40.6 (36.7–44.3)	38.9 (35.6–43.3)	−1.7	0.000^d	38.4 (36.1–41.7)	37.7 (34.6–40.1)	−0.7	0.000^d	0.204^b
WC, cm	126.3 ± 13.3	123.2 ± 13.3	−0.4	0.000^c	124.3 ± 17.2	120.5 ± 16.8	−3.8	0.000^c	122.3 ± 20.6	121.1 ± 20.1	−1.2	0.001^c	0.022^a
HC, cm	128.0 ± 13.3	125.9 ± 13.3	−2.1	0.000^c	130.6 ± 12.9	125.5 ± 11.6	−5.1	0.000^c	119.9 ± 20.6	118.3 ± 19.5	−1.6	0.000^c	0.007^a
WHR	0.99 ± 0.09	0.99 ± 0.11	0.0	0.852^d	0.95 ± 0.1	0.96 ± 0.11	+ 0.01	0.201^d	1.02 ± 0.06	1.03 ± 0.05	−0.01	0.072^d	0.064^b
FM, %	41.0 ± 5.4	40.1 ± 5.7	−0.9	0.031^c	42.1 ± 6.1	41.3 ± 7.1	−0.8	0.142^c	40.9 ± 6.7	39.1 ± 6.9	−1.8	0.000^c	0.112^a
FM, kg	46.9 (41.9–56.2)	44.9 (36.8–52.6)	−2.0	0.002^d	49.7 (41.0–59.6)	46.2 (37.1–56.9)	−3.5	0.001^d	46.7 (40.4–54.1)	41.0 (37.2–51.4)	−5.7	0.000^d	0.381^b
LBM, kg	66.9 (58.6–75.6)	63.6 (55.2–74.8)	−3.3	0.006^d	68.7 (56.5–77.2)	64.3 (56.9–76.5)	− 4.4	0.002^d	70.1 (58.5–80.4)	64.5 (55.1–76.9)	−5.6	0.000^d	0.894^b
VFM, n	15.0 (12.0–21.0)	14.0 (11.0–20.0)	−1.0	0.001^d	14.0 (13.0–21.0)	13.5 (12.0–21.0)	−0.5	0.030^d	16.0 (12.0–20.0)	14.0 (11.0–18.0)	−2.0	0.000^d	0.020^b
TBW, %	41.6 (40.3–44.5)	43.2 (40.5–45.1)	+ 1.6	0.010^d	41.4 (38.7–44.7)	42.8 (39.5–47.6)	+ 1.4	0.014^d	41.8 (39.0–44.9)	42.0 (40.2–46.3)	+ 0.2	0.000^d	0.374^b
TBW, kg	49.1 (43.7–58.9)	47.9 (41.3–56.9)	−1.2	0.014^d	50.6 (42.6–58.1)	48.5 (40.6–59.0)	−2.1	0.012^d	48.6 (41.6–57.0)	49.1 (41.2–58.7)	+ 0.5	0.941^d	0.302^b
ECW, kg	22.7 ± 2.9	22.4 ± 3.2	−0.3	0.142^d	23.1 ± 4.2	22.5 ± 4.1	− 0.6	0.010^d	22.1 ± 3.5	21.9 ± 3.5	− 0.2	0.150^d	0.261^b
ICW, kg	25.6 (23.0–32.9)	25.1 (22.2–31.8)	− 0.5	0.121^d	27.9 (22.5–33.5)	25.8 (21.9–31.6)	−2.1	0.009^d	26.0 (21.4–31.8)	26.6 (21.6–32.0)	+ 0.6	0.241^d	0.142^b

Normally distributed data are represented by mean ± SD and skewed data by the median (interquartile range). P < 0.05 is considered significant (bold highlights)
^aone way ANOVA, ^bKruskal-Wallis test, ^ct- Student’s test, ^dWilcoxon test,
Abbreviations: BMI body mass index, ECW extracellular water, EOS end of study, FM fat mass, HC hip circumference, ICW intracellular water, LBM lean body mass, TBW total body water, VFM visceral fat mass, WC waist circumference, WHR waist-to-hip ratio

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com